Biognosys Launches Spectronaut 16 and Presents Major Advances to its Proteomics Platforms at the ASMS 2022 Annual Conference
Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced the company…
Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced the company…
Biognosys’ leading discovery proteomics services to add depth to NeoGenomics’ multiomics solutions for biopharma cli…
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the deta…
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the laun…
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today that it…
Biognosys, a leading developer and provider of next-generation proteomics technology and solutions, and Thermo Fisher Sc…
Global Medical Sensors Market - Key Players Some of the players leading the market include GE Healthcare, First Sensor…
Global Medical Sensors Market – Segmentations The analysis is segmented into four key dynamics for the convenience of…
. - Expanding collaboration to develop FDA-regulated diagnostics based on exosomes to measure gene mutations targeted b…
Q2 2013 results: Adjusted net sales of $316.4 million (+3% CER) on growth in all regions; adjusted operating income of $…